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Available online xxxxBackground: Seeing one's practice as a high antibiotic prescriber compared to general practices with similar pa-
tient populations can be one of the best motivators for change. Current comparisons are based on age-sex
weighting of the practice population for expected prescribing rates (STAR-PU). Here, we investigate whether
there is a need to additionally account for further potentially legitimatemedical reasons for higher antibiotic pre-
scribing.
Methods: Publicly available data from 7376 general practices in England between April 2014 and March 2015
were used.We built two different negative binomial regressionmodels to compare observed versus expected an-
tibiotic dispensing levels per practice: one including comorbidities as covariates and anotherwith the addition of
smoking prevalence and deprivation. We compared the ranking of practices in terms of items prescribed per
STAR-PU according to i) conventional STAR-PU methodology, ii) observed vs expected prescribing levels using
the comorbidity model, and iii) observed vs expected prescribing levels using the full model.
Findings: The median number of antibiotic items prescribed per practice per STAR-PU was 1.09 (25th–75th per-
centile, 0.92–1.25). 1133 practices (76.8% of 1476) were consistently identiﬁed as being in the top 20% of high
antibiotic prescribers. However, some practices that would be classiﬁed as high prescribers using the current
STAR-PU methodology would not be classiﬁed as high prescribers if comorbidity was accounted for (n = 269,
18.2%) and if additionally smoking prevalence and deprivation were accounted for (n = 312, 21.1%).
Interpretation: Current age-sex weighted comparisons of antibiotic prescribing rates in England are fair for many,
but not all practices. This newmetric that accounts for legitimate medical reasons for higher antibiotic prescrib-
ing may have more credibility among general practitioners and, thus, more likely to be acted upon.
Outstanding Questions: Findings of this study indicate that the antibiotic prescribingmetric bywhich practices are
measured (and need to implement interventions determined)may be inadequate, and therefore raises the ques-
tion of how they should be measured. Substantial variation between practices remains after accounting for co-
morbidities, deprivation and smoking. There is a need for a better understanding of why such variation
remains and, more importantly, what can be done to reduce it. While antibiotics are more frequently indicated
in patients with comorbidities, it is unclear to what extent antibiotic prescribing can be lowered among that pa-
tient population and how this could be achieved.
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Antibiotic resistance (ABR) is increasingly recognised as an impor-
tant threat to modern healthcare [1]. There is strong evidence that anti-
biotic use is one of the major drivers of ABR [2]. In many countries-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1
Oral antibacterial item based STAR-PU weights.










STAR-PU = Speciﬁc Therapeutic Group Age-sex weighting Related Prescribing Unit.
Research in Context
Evidence Before This Study
We searched PubMed for studies evaluating variation in anti-
biotic prescribing in primary care. The papers included in the re-
view were original research studies of any design in which the
criteria for inclusion were: written in English; set in high-
income countries; evaluating variation in antibiotic prescribing
between general practices or benchmarking these practices
based on their antibiotic prescribing rates. We used the following
MeSH terms: “benchmarking” or “practice patterns physicians” or
“small-area analysis” and “antibacterial agents” and any of “pri-
mary health care” or “general practice”. The overall picture was
that non-medical reasons were explaining a substantial part of
the variation in antibiotic prescribing. Identiﬁed factors included
experience of physicians, the patient volume per physician, physi-
cians being trained abroad, lack of access to diagnostic tests, pa-
tient expectations, time pressure and poor doctor-patient
communication. Evidence related to what extent potential legiti-
mate medical reasons explain the variation in antibiotic prescrib-
ing between practices was limited. In England, comparisons
between practiceswere based on prescriptions per practice popu-
lation or using Speciﬁc Therapeutic group Age-sex weight Related
Prescribing Units (STAR-PUs) to account for differing age-sex dis-
tributions of patient populations.
Added Value of This Study
This study found that current STAR-PU based comparisons of
antibiotic prescribing rates in England are fair for many, but not
all practices. Some practices can legitimately claim that they
have a frailer patient population (e.g., relatively high prevalence
of chronic obstructive pulmonary disease, asthma and diabetes)
and prescribe, in line with guidelines in England, more antibiotics
than other practices. Our estimates allow for comparing one's in-
dividual practicewith other practiceswith similar patient popula-
tions in terms of comorbidity prevalences, or also in terms of
smoking prevalence and deprivation.
Implications of All the Available Evidence
Antibiotic prescribing rates vary substantially betweengeneral
practices in England, even after taking into account potential legit-
imate medical reasons for higher prescribing. Our newly devel-
oped metric that accounts for legitimate medical reasons for
higher antibiotic prescribing rates may have higher credibility
among general practitioners and, thus, potentially more likely to
be acted upon, helping endeavours to reduce inappropriate anti-
microbial use in English primary care.
2 E.C. Hope et al. / EClinicalMedicine xxx (xxxx) xxxinappropriate antibiotic prescribing makes up a substantial fraction of
the total prescribing levels, thereby unnecessary increasing ABR levels
[3–5]. The substantial variation that is observed between different gen-
eral practices and countries [3,6]may be interpreted as further evidence
that there is substantial overprescribing in certain practices and areas.
Implementation of interventions designed to lower unnecessary an-
tibiotic prescribing in primary care are often prioritised in general prac-
tices that prescribe above the norm [7]. Prescribing rates between
practices in England are often compared using Speciﬁc Therapeutic
Group Age-sex weighting Related Prescribing Units (STAR-PU)Please cite this article as: E.C. Hope, R.E. Crump, T.D. Hollingsworth, et a
Accounting for Comorbidities and ..., , https://doi.org/10.1016/j.eclinm.201weightings to take into account that speciﬁc age- and gender-groups le-
gitimately receive more antibiotic prescriptions than other groups [8].
Instead of using the unweighted number of registered patients as the
denominator for the antibiotic prescribing rate, the STAR-PU method
gives different weights to registered patients dependent on their age
and sex. For example, females aged between 65 and 74 get a weight of
1.0, while males aged between 25 and 34 get a weight of 0.2 (Table 1).
This methodology has been developed to enable more fair and mean-
ingful comparisons between general practices. Antibiotic prescribing
guidelines indicate that antibiotic prescriptions are more frequently ap-
propriate among very young children or elderly people [9]. In line with
this, antibiotic overprescribing for respiratory tract indications has been
found to be highest amongpatients between 18 and 65years of age [10].
Accounting for sex may also be important because females are biologi-
cally more prone to acquiring urinary tract infections (UTIs) [11].
However, STAR-PU weighting does not account for several other le-
gitimate reasons for variation in antibiotic prescribing. It has previously
been shown that variation in prescribing for respiratory tract infections
(RTIs) is themain driver of differences in antibiotic prescribing rates [3,
4,6]. English guidelines indicate that patientswith RTIs at high risk of se-
rious complications due to pre-existing comorbidity should be offered
an immediate antibiotic prescription and/or further appropriate investi-
gation and management [9,12,13]. Hence, practices with a relatively
high proportion of patients with comorbidities could legitimately pre-
scribe more than a practice with relatively healthy patients. Accounting
for differences in such comorbidities may be necessary for more fair
comparisons of antibiotic prescribing rates of practices.
Ideally, onewould be able to identify high prescribing practices after
accounting for all legitimate reasons for variation in antibiotic prescrib-
ing. In this study we evaluate which practices in England prescribe
above the norm using models that do and do not account for legitimate
medical reasons for variation in antibiotic prescribing. This may help in
reducing antibiotic prescribing, as communicating performancemetrics
(here, e.g., seeing one's practice as an outlier) can be one of the bestmo-
tivators for change [14], especially if being an outlier cannot be ex-
plained by prevalence of comorbidities or other potential legitimate
reasons for higher antibiotic prescribing rates. A method that accounts
for comorbidities, smoking prevalence, and deprivation levels may be
more believed by general practitioners and thus be acted upon.2. Method
Publicly available systemic antibiotic (British National Formulary
chapter 5.1) item-based dispensing data were obtained from NHS Digi-
tal for theﬁnancial yearApril 2014 –March2015 (http://content.digital.
nhs.uk). For each practice in England, antibiotics that are prescribed and
subsequently dispensed in the community are included in this dataset.
Other publicly available data that were obtained from NHS Digital in-
cluded: the number of patients registered at each practice split into gen-
der and ﬁve year age bands, comorbidity prevalences, and oral
antibacterials items-based STAR-PU weights [8].l., Identifying English Practices that Are High Antibiotic Prescribers
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Table 2





Simple linear association with








CHD prevalence 3.27 (2.50–4.01) 1.043 (1.037–1.050)
Diabetes prevalence 6.52 (5.53–7.52) 1.020 (1.016–1.024)
HF prevalence 0.69 (0.49–0.90) 1.063 (1.042–1.085)
Asthma prevalence 5.99 (5.15–6.81) 1.048 (1.042–1.054)
COPD prevalence 1.75 (1.23–2.39) 1.090 (1.081–1.098)
Cancer prevalence 2.22 (1.60–2.77) 0.983 (0.975–0.992)
CKD prevalence 3.87 (2.67–5.24) 1.007 (1.004–1.011)
CHD= chronic heart disease. CKD= chronic kidney disease. COPD= chronic obstructive
pulmonary disease. HF = heart failure. STAR-PU = Speciﬁc Therapeutic Group Age-sex
weighting Related Prescribing Unit.
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theQuality andOutcomes Framework (QOF) data and included: asthma
(excluding patients who have not been prescribed asthma-related
drugs in the preceding 12 months), chronic obstructive pulmonary dis-
ease (COPD), coronary heart disease, heart failure, cancer (excludingpa-
tients with non-melanotic skin cancers), chronic kidney disease
(excluding patientswith chronic kidney disease stage b3), and diabetes.
These comorbidities were selected as potential legitimate reasons for
variation in antibiotic prescribing, because they are considered as fac-
tors that are associated with worse infection-related outcomes [13]. En-
glish guidelines recommend considering an immediate antibiotic
prescription in patientswith RTIs and these comorbidities [9,12]. In con-
trast, in patients without such comorbidities immediate antibiotics are
generally not recommended [12,13].
Another legitimate cause of variation in antibiotic prescribing is the
smoking prevalence of the patient population. Both active and passive
smoking are associated with an increased risk of infection and worse
outcomes [15,16]. Local smoking prevalences were obtained from the
Smoking prevalence for local and unitary authorities in England data-
base [17].
The Index of Multiple Deprivation (IMD) was included, because
there is evidence that living conditions are associatedwith the risk of re-
spiratory tract infections [18,19]. Moreover, other lifestyle factors par-
tially captured by the IMD may be associated with an increased risk of
infection [15]. This index is available from the Department for Commu-
nities and Local Government (now named the ‘Ministry of Housing,
Communities & Local Government’) which ranks very small areas
(~1500 people) called lower-layer super output areas (LSOAs), accord-
ing to a weighted score for employment, income, education, health,
crime, living environment, and barriers to housing and services [20].
The IMD was linked to each practice based on the LSOAs the practice
was serving; the smoking prevalence was linked to each practice
based on the local authority the practice served.
2.1. Analyses
For the primary analysis, we created a dataset including only prac-
tices with nomissing data for any of the predictors. In line with a previ-
ous study [21], we excluded practices with a list size of fewer than 750
patients, as these practices were likely newly formed or about to close.
The dispensing dataset initially contained data on 7934 practices. Of
these, 486 (6%) practices were removed due to missing data. The most
common reasonsweremissing information on comorbidity prevalences
(n=357) and smoking prevalence (n=127). After excluding practices
with missing information, 7448 practices remained. After additionally
removing practices with less than 750 registered patients, 7376 prac-
tices remained.
The ranking of practices based on their antibiotic prescribing rate per
STAR-PU is straightforward. This can be accomplished by dividing the
number of antibiotic items by the amount of STAR-PU for each practice
and subsequently sorting the practices based on the obtained values. To
additionally take into account other legitimate medical reasons for var-
iation in antibiotic prescribing, we build two negative binomial regres-
sion models in order to evaluate the association between included
predictors and antibiotic prescribing rates per STAR-PU at the practice
level. The natural logarithm of the amount of STAR-PU per practice
was included as on offset to take into account differences in practice
sizes and age- and gender distributions of the practices. We built two
different models: i) a model with only comorbidity prevalences as po-
tential predictors, ii) a model with comorbidities, deprivation score,
and smoking prevalence as potential predictors. We did not consider
non-linearity for comorbidities and the smoking prevalence, because
we assumed that the medical legitimacy of an antibiotic prescription
for an individual is independent of the total number of smokers or pa-
tients with comorbidities registered with a practice. The IMD was
categorised based on the quintiles of its distribution.Please cite this article as: E.C. Hope, R.E. Crump, T.D. Hollingsworth, et a
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lected for inclusion in the model using stepwise backward selection
based on the Akaike Information Criterion (AIC). Subsequently, we re-
moved variables that had a negative association with the antibiotic pre-
scribing rate from themodel, because tomake the comparison between
practices more fair we wanted to only take into account factors that
both in theory and in practice are associated with higher (legitimate)
antibiotic prescribing rates.
To evaluate to what extent the models could explain the differences
in antibiotic prescribing, we estimated the amount of deviance ex-
plained by each model. To enable a fair comparison of the deviance ex-
plained by each model, we ﬁxed the dispersion parameter at the
estimate derived for themodel which considered all variables as poten-
tial predictors.
We subsequently evaluated whether the same practices would be
identiﬁed as being among the top 20% regarding their antibiotic pre-
scribing rate when ranking them according to the current methodology
using antibiotic items per STAR-PU versus towhat extent a practice pre-
scribes above or below their predicted antibiotic prescribing rate per
STAR-PU. The latter was calculated by taking the observed prescribing
rate per STAR-PU minus the predicted prescribing rate per STAR-PU.
The predicted prescribing rate per STAR-PU was obtained using the
model with comorbidity only and the model considering all factors
listed above. An area-proportional Venn diagram was used to visualise
to what extent different practices were among the top 20% of antibiotic
prescribers using the current methodology and the new model-based
methodologies. All analyses were performed using R, version 3.3.2.
2.2. Sensitivity Analyses
For the primary analysis, we excluded practices that had fewer than
750 registered patients. However, after excluding those practices, a few
practices remained with questionable high/low antibiotic prescribing
rates per STAR-PU (e.g. 0.05 or 17.14 antibiotics per STAR-PU). As we
could not exclude the possibility that some of these practices were gen-
uinely prescribingmuchmore or less thanmost other practices, we kept
them in the primary analyses. For sensitivity analyses, we further re-
stricted the data used in the primary analyses by only using data from
practices that had a prescribing rate between 1/3 and 3 antibiotics per
STAR-PU. Values outside this range are less likely to be correct. Such im-
plausible antibiotic prescribing rates may be due to data entry errors or
due to the fact that a practice serves relatively many patients that are
not registered at the practice, which increases the numerator but not
the denominator.
Because one may argue whether the prevalence of some of the in-
cluded comorbidities could be considered legitimate reasons for higher
antibiotic prescribing rates, we added a sensitivity analysis with amuchl., Identifying English Practices that Are High Antibiotic Prescribers
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4 E.C. Hope et al. / EClinicalMedicine xxx (xxxx) xxxmore restricted model only taking into account the COPD and diabetes
prevalence.Fig. 1. Venn diagram of identifying top 20% of practices in terms of antibiotic prescribing
rate per STAR-PU using three different methodologies. The full model considered all
variables (blue ellipse, see Table 2), the comorbidity model considered only
comorbidities (pink ellipse, see Table 2) and the current methodology is based on
ranking practices based on their antibiotic prescribing rate per STAR-PU without taking
into account any other variables (yellow ellipse). STAR-PU: Speciﬁc Therapeutic Group
Age-sex weighting Related Prescribing Unit.3. Results
The characteristics of patients registered at the 7376 included prac-
tices are summarised in Table 2. The median number of antibiotic items
prescribed per STAR-PUwas 1.09 (25th -75th percentile, 0.92–1.25) be-
tween April 2014 andMarch 2015 (Table 2). In univariate analysis, most
potential predictors were associated with a higher use of antibiotics per
STAR-PU. The only exception was the cancer prevalence which had a
negative association with the antibiotic prescribing rate (Table 2). The
number of antibiotics prescriptions per STAR-PU was higher among
practices from more deprived areas. Taking the ﬁrst quintile of the
IMDas a reference, the incidence rate ratios increasedwith each quintile
(2nd: 1.010 (95% CI 0.978–1.043); 3rd: 1.028 (95%CI 0.995–1.061); 4th:
1.064 (95% CI 1.030–1.098); 5th 1.103 (95% CI 1.069–1.139)).
The negative binomial regressionmodel, which only allowed comor-
bidities to be selected as predictors, included the asthma (RR 1.025, 95%
CI 1.016–1.035), COPD (RR 1.070, 95% CI 1.056–1.084) and diabetes
prevalence (RR 1.008, 95% CI 1.003–1.014) as predictors of higher anti-
biotic use per STAR-PU (Table 3). This model explained 7.5% of the devi-
ance. The second negative binomial regression model additionally
allowed the smoking prevalence and IMD to be selected as predictors.
After stepwise variable selection, this second model included the same
comorbidities as model 1, but additionally included the smoking preva-
lence (RR 1.005, 95% CI 1.003–1.007) and IMD quintiles as predictors
(2nd: RR 1.000, 95% CI 0.978–1.022; 3rd: RR 1.010, 95% CI
0.987–1.033; 4th: RR 1.044, 95% CI 1.020–1.069; 5th: RR 1.095, 95% CI
1.068–1.122) (Table 3). This model explained 9.1% of the deviance.
The Venn diagram in Fig. 1 shows that there is substantial overlap
between the current methodology based on STAR-PU and the model-
based methodologies that take into account comorbidities alone or co-
morbidities, smoking prevalence, and IMD together. There was varia-
tion in which 1476 (top 20%) practices were included by the three
different methods. The three different methods agreed on 1133 prac-
tices (76.8% of 1476) being high antibiotic prescribers. However, some
practices that are classiﬁed as high prescribers using the current STAR-
PU methodology are not classiﬁed as high prescribers when taking
into account comorbidities alone (n = 269, 18.2%) or comorbidities,
smoking prevalence, and IMD (n = 312, 21.1%). Similarly, some prac-
tices that are not identiﬁed as high prescribers using current STAR-PU
methodology are classiﬁed as high prescribing using one (n = 159) or
both (n = 211) of the new model-based approaches.
The difference in ranking of all included practices, including those
never identiﬁed as being among the top 20% antibiotic prescribers,
based on the different methodologies is shown in Table S1. The same
identiﬁable practice code as used in the publicly available data is in-
cluded in this table, to enable practices to identify their own practice.Table 3
Estimated associations between predictor variables and number of antibiotics per STAR-
PU.
Predictor Comorbidity model
Relative risk (95% CI)
Full model
Relative risk (95% CI)
Asthma prevalence 1.025 (1.016–1.035) 1.034 (1.027–1.040)
COPD prevalence 1.070 (1.056–1.084) 1.059 (1.049–1.068)
Diabetes prevalence 1.008 (1.003–1.014) 1.002 (0.998–1.006)
Smoking prevalence NA 1.005 (1.003–1.007)
Deprivation 1 NA Ref.
Deprivation 2 NA 1.000 (0.978–1.022)
Deprivation 3 NA 1.010 (0.987–1.033)
Deprivation 4 NA 1.044 (1.020–1.069)
Deprivation 5 NA 1.095 (1.068–1.122)
COPD = chronic obstructive pulmonary disease. STAR-PU = Speciﬁc Therapeutic Group
Age-sex weighting Related Prescribing Unit.
Please cite this article as: E.C. Hope, R.E. Crump, T.D. Hollingsworth, et a
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When only taking into account the prevalence of diabetes and COPD,
results were very similar to the model that also allowed for other co-
morbidities. These two methods agreed on 1368 (92.7% of 1476)
being high antibiotic prescribers.
In a subsequent sensitivity analysis, 7311 practices remained after
excluding practices with antibiotic prescribing rates per STAR-PU
below 1/3 or above 3. Besides the comorbidities selected in the main
analysis, the coronary heart disease prevalence (RR 1.028, 95%
1.021–1.035) was also included in the ﬁnal comorbidity only model
(Table 4). This model explained 19.1% of the deviance. The ﬁnal
model, which considered all variables as potential predictors, was sim-
ilar to the main analysis, except that the IMD was no longer included
in the ﬁnal model (19.4% of deviance explained).
Similar to themain analysis, there is substantial overlap between the
differentmethodologies to identify the top 20% of antibiotic prescribers.
In 1104 out of 1463 (75.5%) the STAR-PU basedmethod and themodel-
basedmethods agree onwhich practices are among the top 20% highest
antibiotic prescribers (Fig. 2). Table S2 shows the ranking of all practices
based on the three different methodologies.
4. Discussion
This study found that current comparisons of antibiotic prescribing
rates of general practices based on STAR-PU weighting only may beTable 4
Estimated associations between predictor variables and number of antibiotics per STAR-
PU after removing outer 1% in terms of antibiotic prescribing rate per STAR-PU.
Predictor Comorbidity model
Relative risk (95% CI)
Full model
Relative risk (95% CI)
Asthma prevalence 1.021 (1.016–1.026) 1.022 (1.017–1.026)
COPD prevalence 1.058 (1.050–1.066) 1.050 (1.042–1.058)
Diabetes prevalence 1.023 (1.020–1.026) 1.022 (1.019–1.025)
CHD prevalence 1.028 (1.021–1.035) 1.029 (1.022–1.036)
Smoking prevalence NA 1.004 (1.003–1.006)
CHD= coronary heart disease. COPD= chronic obstructive pulmonary disease. STAR-PU
= Speciﬁc Therapeutic Group Age-sex weighting Related Prescribing Unit.
l., Identifying English Practices that Are High Antibiotic Prescribers
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Fig. 2. Venn diagram of identifying top 20% of practices in terms of antibiotic prescribing
rate per STAR-PU using three different methodologies, after removing outer 1% of
practices based on antibiotic prescribing rate per STAR-PU. The full model considered all
variables (blue ellipse, see Table 2), the comorbidity model considered only
comorbidities (pink ellipse, see Table 2) and the current methodology is based on
ranking practices based on their antibiotic prescribing rate per STAR-PU without taking
into account any other variables (yellow ellipse). STAR-PU: Speciﬁc Therapeutic Group
Age-sex weighting Related Prescribing Unit.
5E.C. Hope et al. / EClinicalMedicine xxx (xxxx) xxxunfair for somepractices. Although STAR-PUweighting does account for
differences in the age and gender distribution of patient populations,
using STAR-PU weighting alone results in practices being identiﬁed as
high antibiotic prescribers which would not be ranked so highly when
also taking into account other legitimate reasons for variation, such as
comorbidities. Similarly, some practices with relatively healthy popula-
tions are missed as high prescribers when using only STAR-PU
weightings.
4.1. Strength and Weaknesses of Study
This study used publicly available data, covering all patients regis-
tered with a general NHS practice in England. There are several studies
that tried to ﬁnd reasons why some practices prescribe substantially
more antibiotics than other practices [6,21–24] and some have sug-
gested that comparisons between practices should take into account po-
tentially legitimate reasons for higher antibiotic prescribing rates [24].
However, to our knowledge no study has compared practices prescrib-
ing rates accounting for additional legitimate reasons for prescribing
using data available at a national level. Our study has direct policy impli-
cations because individual practices that are still identiﬁed as prescrib-
ing above the norm even after accounting for comorbidities and other
legitimate reasons for higher antibiotic prescribing rates, can be identi-
ﬁed at a national level, thus helping to inform intervention decisions.
Although comorbidity prevalences were available at the practice
level, other predictors could only be linked to a practice based on the
local authorities the practice served. This could result in biased esti-
mates if, for example, a practice in a relatively deprived area attracted
patients with a higher socioeconomic status while all other patients at-
tend other practices in the area. Potential legitimate reasons for higher
prescribing in certain practices not available for this study include, for
example, the prevalence of immunosuppressive diseases, consultation
rates, and markers of the severity of infections [6,25]. However, immu-
nosuppressive diseases are relatively rare and are therefore unlikely to
explain a lot of the variation in antibiotic prescribing [6]. Although RTI
consultation rates seem to explain a substantial part of the variation in
antibiotic prescribing [6], it is at least questionable whether thesePlease cite this article as: E.C. Hope, R.E. Crump, T.D. Hollingsworth, et a
Accounting for Comorbidities and ..., , https://doi.org/10.1016/j.eclinm.201consultations differ due to true differences in medical need [6]. Differ-
ences in consultation rates may instead reﬂect difference in health-
care seeking behaviour and it has previously been shown that high an-
tibiotic prescribing rates result in higher consultation rates and
medicalisation of self-limiting infections [26]. Because it is questionable
whether (apparent) higher consultation rates reﬂect legitimatemedical
reasons for higher antibiotic prescribing rates, accounting for differ-
ences in consultation rates – if available – would not necessarily lead
to more fair comparisons.
Beyond the issue of potentially not having included all medically le-
gitimate reasons for variations in antibiotic prescribing, the model-
based approaches require a valid model to obtain predicted antibiotic
prescribing rates per STAR-PU for every practice given the characteris-
tics of their patient population. A model additionally including comor-
bidities that had a negative association with the antibiotic prescribing
rate and non-linear functions for continuous variables would be better
at explaining the variation between practices [6]. However, we decided
to include only variables for which clear theoretical medical reasons
why they may be associated with higher antibiotic prescribing rates
existed, i.e. according to guidelines or based on the literature, and for
which in practice a positive association with the antibiotic prescribing
rate per STAR-PU was observed. The percentage of deviance explained
was relatively low, indicating that a large part of the variation in antibi-
otic prescribing is not explained by the considered legitimate medical
reasons for variation in prescribing. Potential reasons for variation in an-
tibiotic prescribing that do not represent legitimate medical reasons in-
clude for example variation in inappropriate prescribing and health-
care seeking behaviour of the patient population [3,4,6].
Although guidelines indicate that practices with more patients with
comorbidities could legitimately prescribemore antibiotics for RTIs, the
relationship between comorbidities and antibiotic prescribing for
suspected UTI is complex. Asymptomatic bacteriuria is associated with
comorbidity and frequently inappropriately treated with antibiotics in
nursing homes [27]. However, at the general practice level, variation
in antibiotic prescribing for RTIs – for which guidelines indicate that co-
morbidities are legitimate reasons for a higher likelihood of prescribing
– is much more relevant in explaining variation in total antibiotic pre-
scribing [3,6].
It is important to note that this study does not address the issues of
what constitutes ‘safe’ levels of prescribing orwhat proportion of antibi-
otics is inappropriate. In other words, this study seeks to rank practices'
antibiotic prescribing in a fairmanner, but it provides no insight into ap-
propriate absolute levels of prescribing. If themajority of practices were
overprescribing, the expected antibiotic prescribing rate from the
model would still include a substantial proportion of inappropriate an-
tibiotic prescriptions. Other recent work has attempted to quantify in-
appropriate prescribing in English primary care [3,4]. That work
indicates that even currently low prescribing English practices overpre-
scribe antibiotics [3,4].
4.2. Implications
Several countries, including England, currently aim to reduce inap-
propriate antibiotic prescribing in order to tackle the problem of in-
creasing levels of antibiotic resistance. The ﬁndings presented here
can be used to identify practices that prescribe above the norm, even
when taking into account age and sex distributions, the prevalence of
comorbidities, smoking and deprivation of the patient population.
These results can also be used to better identify high prescribing prac-
tices and target interventions designed to reduce antibiotic prescribing
in those practices which might have a much greater potential to lower
antibiotic prescribing rates. By identifying factors that are both in theory
and in practice associated with higher antibiotic prescribing rates, this
work may create a rational basis for incentivising stewardship with re-
lation to different population groups. Although these factors can be con-
sidered as legitimate medical reasons for higher antibiotic prescribingl., Identifying English Practices that Are High Antibiotic Prescribers
8.12.003
6 E.C. Hope et al. / EClinicalMedicine xxx (xxxx) xxxrates, they include factors that can either be directly modiﬁed, such as
smoking prevalence [28], or via underlying risk factors such as lifestyle
interventions to prevent diabetes [29].
Given that themodel is based onpublicly available datawhich is reg-
ularly updated, the model can be updated on a regular basis to reﬂect
changes in prescribing and underlying patient populations.
5. Conclusion
Current age- and sex-weighted comparisons of antibiotic prescrib-
ing rates in England are fair for most, but not all practices. Some prac-
tices can legitimately claim that they have a more frail patient
population and prescribe, in line with guidelines in England, more anti-
biotics than other practices. After additionally accounting for preva-
lences in comorbidity such practices would no longer be identiﬁed as
being among the top 20% of high prescribers (yet, it is still possible
that they overprescribe antibiotics). Similarly, other, currently missed,
practices would move into the ‘high prescriber’ category if more inclu-
sive methods were adopted. Our study produced a tool that can be reg-
ularly updated and ﬁne-tuned using publicly available data in order to
facilitatemore fair and up-to-date comparisons of antibiotic prescribing
rates of general practices in England.
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